TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies. Through its self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR, datasets, and consulting partnerships, TriNetX puts the power of real-world data into the hands of its worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.
$40M sweet spot round size
$40M
from 2 investors over 1 rounds
TriNetX raised $40M on April 13, 2019
Investors: Merck Global Health Innovation Fund and + 5 Other investors